Orthocell Limited (ASX:OCC)
Australia · Delayed Price · Currency is AUD 0.5650
-0.0350 (-5.83%)
Oct 22, 2026, 10:32 AM AEDT
Orthocell Market Cap
Orthocell has a market cap or net worth of 153.9 million as of October 21, 2026. It is the 24,136th most valuable company in the world and the 504th biggest in Australia. Its market cap has decreased by 53.31% in one year.
Market Cap
153.90M
Enterprise Value
110.92M
Revenue
11.41M
Global Rank
Country Rank
#504 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 12, 2014, Orthocell's market cap has increased from 29.70M to 153.90M, an increase of 418.19%. That is a compound annual growth rate of 14.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 163.44M | -44.48% |
| Dec 31, 2025 | 294.37M | -9.37% |
| Dec 31, 2024 | 324.80M | 297.55% |
| Dec 29, 2023 | 81.70M | 1.05% |
| Dec 30, 2022 | 80.85M | -19.58% |
| Dec 31, 2021 | 100.54M | 20.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Racura Oncology | 311.75M |
| Tetratherix | 278.56M |
| Starpharma Holdings | 239.87M |
| BLS Pharmaceuticals | 230.30M |
| Actinogen Medical | 165.46M |
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 123.08M |
| Recce Pharmaceuticals | 107.02M |